Jungyeon Kim Selected Research

Jungyeon Kim Research Topics

4	COVID-19 03/2024 - 10/2022
3	Behcet Syndrome (Behcet's Syndrome) 01/2018 - 01/2015
2	Critical Illness (Critically Ill) 11/2023 - 07/2023
2	Inflammation (Inflammations) 12/2016 - 01/2015
2	Breast Neoplasms (Breast Cancer) 08/2006 - 09/2003
1	Infections 07/2023
1	Respiratory Sounds (Crackle) 01/2022
1	Ambulatory Care Sensitive Conditions 01/2021
1	Hepatitis C 01/2019
1	Fungal Meningitis 01/2017
1	Hyperplasia 12/2016
1	Rheumatoid Arthritis 01/2015
1	Arthritis (Polyarthritis) 01/2015

3	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2015
2	nirmatrelvir and ritonavir drug combinationIBA 03/2024 - 07/2023
2	Antiviral Agents (Antivirals)IBA 07/2023 - 01/2019
2	CitrullineIBA 01/2015 - 01/2015
1	molnupiravirIBA 11/2023
1	remdesivirIBA 10/2022
1	Oxygen (Dioxygen)IBA 10/2022
1	Calcium Gluconate (CBG)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Aquaporins (Water Channels)IBA 01/2017
1	Amino Acids FDA Link 12/2016
1	SugarsIBA 12/2016
1	CurcuminIBA 01/2015
1	Urea (Carbamide)FDA LinkGeneric 01/2015
1	Valine (L-Valine)FDA Link 01/2015
1	methionine sulfoxideIBA 01/2015
1	citramalateIBA 01/2015
1	Arachidonic Acid (Vitamin F)IBA 01/2015
1	Phosphates (Orthophosphate)IBA 01/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2015
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2015
1	Isoleucine (L-Isoleucine)FDA Link 01/2015
1	Leucine (L-Leucine)FDA Link 01/2015
1	Lysine (L-Lysine)FDA Link 01/2015
1	Glutamic Acid (Glutamate)FDA Link 01/2015
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 08/2006
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2006

2	Drug Therapy (Chemotherapy) 08/2006 - 09/2003
1	Therapeutics 10/2022
1	Mechanical Ventilators (Ventilator) 01/2022
1	Aftercare (After-Treatment) 01/2015
1	Adjuvant Chemotherapy 08/2006